Cargando…
Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache
Background: To determine the prevalence of Idiopathic intracranial hypertension without papilledema (IIHWOP) testing revised diagnostic criteria by Friedman in refractory chronic headache (CH) patients. Methods: This is a prospective observational study. Each patient underwent ophthalmologic evaluat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029151/ https://www.ncbi.nlm.nih.gov/pubmed/29997572 http://dx.doi.org/10.3389/fneur.2018.00503 |
_version_ | 1783336905184641024 |
---|---|
author | Favoni, Valentina Pierangeli, Giulia Toni, Francesco Cirillo, Luigi La Morgia, Chiara Abu-Rumeileh, Samir Messia, Monica Agati, Raffaele Cortelli, Pietro Cevoli, Sabina |
author_facet | Favoni, Valentina Pierangeli, Giulia Toni, Francesco Cirillo, Luigi La Morgia, Chiara Abu-Rumeileh, Samir Messia, Monica Agati, Raffaele Cortelli, Pietro Cevoli, Sabina |
author_sort | Favoni, Valentina |
collection | PubMed |
description | Background: To determine the prevalence of Idiopathic intracranial hypertension without papilledema (IIHWOP) testing revised diagnostic criteria by Friedman in refractory chronic headache (CH) patients. Methods: This is a prospective observational study. Each patient underwent ophthalmologic evaluation and Optical Coherence Tomography; brain magnetic resonance venography (MRV) and a lumbar puncture (LP) with opening pressure (OP) measurement. CSF withdrawal was performed in patients with CSF OP > 200 mmH20. IIHWOP was defined according Friedman's diagnostic criteria. Effect of CSF withdrawal was evaluated clinically in a 6-month follow-up and with a MRV study at 1 month. Results: Forty-five consecutive patients were enrolled. Five were excluded due to protocol violations. Analyses were conducted in 40 patients (32 F, 8 M; mean age 49.4 ± 10.8). None had papilledema. Nine patients (22.5%) had OP greater than 200 mmH2O, two of them above 250 mmH2O. Two (5%) had neuroimaging findings suggestive of elevated intracranial pressure. One of them (2.5%) met the newly proposed diagnostic criteria by Friedman for IIHWOP. After CSF withdrawal seven (77.8%) of the nine patients improved. No changes in neuroimaging findings were found. Conclusions: We found a low prevalence (2.5%) of IIHWOP in refractory CH patients according to current diagnostic criteria. In agreement with Friedman's criteria, our results confirm that a diagnosis of IIHWOP should be based on CSF OP and the combination of neuroradiological findings. However, where to set the CSF OP upper limit in IIHWOP needs further field testing. Although IIHWOP is a rare clinical condition, it should be considered and treated in refractory CH patients. |
format | Online Article Text |
id | pubmed-6029151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60291512018-07-11 Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache Favoni, Valentina Pierangeli, Giulia Toni, Francesco Cirillo, Luigi La Morgia, Chiara Abu-Rumeileh, Samir Messia, Monica Agati, Raffaele Cortelli, Pietro Cevoli, Sabina Front Neurol Neurology Background: To determine the prevalence of Idiopathic intracranial hypertension without papilledema (IIHWOP) testing revised diagnostic criteria by Friedman in refractory chronic headache (CH) patients. Methods: This is a prospective observational study. Each patient underwent ophthalmologic evaluation and Optical Coherence Tomography; brain magnetic resonance venography (MRV) and a lumbar puncture (LP) with opening pressure (OP) measurement. CSF withdrawal was performed in patients with CSF OP > 200 mmH20. IIHWOP was defined according Friedman's diagnostic criteria. Effect of CSF withdrawal was evaluated clinically in a 6-month follow-up and with a MRV study at 1 month. Results: Forty-five consecutive patients were enrolled. Five were excluded due to protocol violations. Analyses were conducted in 40 patients (32 F, 8 M; mean age 49.4 ± 10.8). None had papilledema. Nine patients (22.5%) had OP greater than 200 mmH2O, two of them above 250 mmH2O. Two (5%) had neuroimaging findings suggestive of elevated intracranial pressure. One of them (2.5%) met the newly proposed diagnostic criteria by Friedman for IIHWOP. After CSF withdrawal seven (77.8%) of the nine patients improved. No changes in neuroimaging findings were found. Conclusions: We found a low prevalence (2.5%) of IIHWOP in refractory CH patients according to current diagnostic criteria. In agreement with Friedman's criteria, our results confirm that a diagnosis of IIHWOP should be based on CSF OP and the combination of neuroradiological findings. However, where to set the CSF OP upper limit in IIHWOP needs further field testing. Although IIHWOP is a rare clinical condition, it should be considered and treated in refractory CH patients. Frontiers Media S.A. 2018-06-26 /pmc/articles/PMC6029151/ /pubmed/29997572 http://dx.doi.org/10.3389/fneur.2018.00503 Text en Copyright © 2018 Favoni, Pierangeli, Toni, Cirillo, La Morgia, Abu-Rumeileh, Messia, Agati, Cortelli and Cevoli. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Favoni, Valentina Pierangeli, Giulia Toni, Francesco Cirillo, Luigi La Morgia, Chiara Abu-Rumeileh, Samir Messia, Monica Agati, Raffaele Cortelli, Pietro Cevoli, Sabina Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache |
title | Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache |
title_full | Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache |
title_fullStr | Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache |
title_full_unstemmed | Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache |
title_short | Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache |
title_sort | idiopathic intracranial hypertension without papilledema (iihwop) in chronic refractory headache |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029151/ https://www.ncbi.nlm.nih.gov/pubmed/29997572 http://dx.doi.org/10.3389/fneur.2018.00503 |
work_keys_str_mv | AT favonivalentina idiopathicintracranialhypertensionwithoutpapilledemaiihwopinchronicrefractoryheadache AT pierangeligiulia idiopathicintracranialhypertensionwithoutpapilledemaiihwopinchronicrefractoryheadache AT tonifrancesco idiopathicintracranialhypertensionwithoutpapilledemaiihwopinchronicrefractoryheadache AT cirilloluigi idiopathicintracranialhypertensionwithoutpapilledemaiihwopinchronicrefractoryheadache AT lamorgiachiara idiopathicintracranialhypertensionwithoutpapilledemaiihwopinchronicrefractoryheadache AT aburumeilehsamir idiopathicintracranialhypertensionwithoutpapilledemaiihwopinchronicrefractoryheadache AT messiamonica idiopathicintracranialhypertensionwithoutpapilledemaiihwopinchronicrefractoryheadache AT agatiraffaele idiopathicintracranialhypertensionwithoutpapilledemaiihwopinchronicrefractoryheadache AT cortellipietro idiopathicintracranialhypertensionwithoutpapilledemaiihwopinchronicrefractoryheadache AT cevolisabina idiopathicintracranialhypertensionwithoutpapilledemaiihwopinchronicrefractoryheadache |